NGNE Operating Cash Flow (Statement)
Neurogene Inc · Operating Cash Flow (Statement)
NGNE Operating Cash Flow (Statement)
Latest reported-$86.24Mperiod ending
NGNE TTM Cash from Operations (-$45.66M → -$86.24M)
TTM operating cash flow (statement)
High-resolution chart · PNG
NGNE operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -86,236,271 | |
| -81,937,271 | |
| -76,592,271 | |
| -77,414,590 | |
| -73,296,000 | |
| -69,727,000 | |
| -70,603,000 | |
| -82,622,868 | |
| -78,626,868 | |
| -72,060,868 | |
| -63,965,868 | |
| -44,630,000 | |
| -41,839,223 | |
| -43,703,949 | |
| -44,239,949 | |
| -46,126,573 | |
| -45,533,843 | |
| -48,031,803 | |
| -47,298,803 | |
| -44,975,186 | |
| -37,331,932 | |
| -32,214,161 | |
| -25,296,161 | |
| -20,188,001 | |
| -26,273,468 | |
| -19,158,158 | |
| -22,243,473 | |
| -32,731,147 | |
| -16,859,065 | |
| -30,991,460 | |
| -32,527,757 | |
| -30,588,641 | |
| -49,967,061 | |
| -45,658,061 | |
| -43,014,256 | |
| -37,191,494 |